CClinicalTrials.gg
CompletedNCT03029312Updated Jan 24, 2017

Whole Body Vibration Training in Children With Osteogenesis Imperfecta and Limited Mobility

An interventional study of Galileo M in Osteogenesis Imperfecta, sponsored by Birmingham Women's and Children's NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to participants aged 5 Years to 16 Years. Per ClinicalTrials.gov, last updated 2017-01-24.

Sponsored by Birmingham Women's and Children's NHS Foundation Trust · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 years after the study started (first participant enrolled Jan 2012, registered Jan 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
5 Years to 16 Years
Sex
All
01

Study summary

Children with osteogenesis imperfecta (OI) have impaired bone strength, fractures, weak muscles and limited mobility. Mild to moderate forms of OI (type 1 and 4) may benefit from muscle training that leads to secondary improvement in bone strength (osteogenic treatment). Recent studies in children with cerebral palsy but also OI suggest that Whole Body Vibration Training (WBVT) improves mobility and also bone strength. No randomized controlled trials exist in OI children. This randomized controlled pilot study assesses the effect of 5 months WBVT (2 x 9min/day) on muscle function, mobility, bone structure and density. 24 children >5 years with OI type 1 and 4 with limited mobility (CHAQ Score ≥0.13) will be randomized into a WBVT group and a control group matched by gender and pubertal stage. Main outcome measure is the change in tibial volumetric BMD, secondary outcomes include a variety of bone, mobility and dynamic muscle function variables.

Read the detailed description

Osteogenesis imperfecta (OI) is a bone fragility disorder with impaired bone strength, fractures, weak muscles and limited mobility. Mild to moderate forms of OI (type 1 and 4) may not require bisphosphonate therapy but would benefit from muscle training that leads to secondary improvement in bone strength (osteogenic treatment). The mechanostat theory states that bone adapts its strength to mechanical forces mostly imposed by muscle. According to this widely accepted theory, any treatment that strengthens muscle should also strengthen bones. Whole body vibration therapy (WBVT) with side-alternating platforms (Galileo™) uses the body's neuromotor reflex system to train muscles. Recent studies in children with cerebral palsy but also OI suggest that WBVT improves mobility and also bone strength. No randomized controlled trials exist in OI children.

This randomized controlled study assesses the effect of 5 months whole body vibration training (2 x 9min/day) on muscle strength, motor function, bone structure and density. 24 children >5 years with OI type 1 and 4 with limited mobility (CHAQ Score ≥0.13) will be randomized into a WBVT group and a control group matched by gender and pubertal stage. Children with OI will be recruited from specialist clinics in Birmingham, Manchester and Sheffield, as well as via advertisement on the Brittle Bone Society's homepage. Patients will be equipped with side-alternating vibration platforms for home use and train with increasing intensity. Outcome measures are tested pre- and post 5-months intervention. Dynamic muscle function is measured by mechanography (jumping force plates) and mobility by CHAQ questionnaire and a six-minute walk test. Changes in bone structure and density are assessed by DXA and peripheral QCT of the tibia.

02

Conditions studied

  • Osteogenesis Imperfecta

Keywords

  • whole body vibration
  • Muscle function
  • Physical activity
  • bone density
03

In context

Osteogenesis Imperfecta

85 studies on the registry are indexed under Osteogenesis Imperfecta; 20 are open to participants now.

This study's enrollment of 24 is close to the median of 26 across 59 interventional studies indexed under Osteogenesis Imperfecta.

Browse Osteogenesis Imperfecta studies →

Lead sponsor

Birmingham Women's and Children's NHS Foundation Trust is the lead sponsor of 17 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Patients with mild OI (type 1 and 4; >5y of age) who need to be at least partly ambulant and have a CHAQ score of greater than 0.13, constituting at least mild disability. Minimum requirement is the ability to rise from a chair.

Informed consent is required from the participant and/or parent/guardian.

Exclusion criteria

-

Exclusion Criteria:

  • On bisphosphonate treatment for less than 2years (since mobility usually improves during the initial phase treatment).
  • Finished bisphosphonate therapy less than 6 months ago
  • Recent lower limb fracture \<3months ago, or upper limb fracture which is still in plaster.
  • Heart or lung disease, use of steroids (oral, systemic, topical or inhaled, for more than 3 weeks in the last 12 months) or any other bone-active treatment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Whole Body Vibration

    Twice daily WBVT at home using the Galileo M device, 3x3 min, with 3 minute breaks (total daily WBVT 18 min) for 5 months. Children stand upright on the device, with knees bent (10-45 degrees, semi-squat or squat position). A schedule of increasing intensity of vibration exercise was used over time, allowing some adjustment to the patient's physical capability. Amplitude 1 was used for the first 2 weeks, then increased to amplitude 2 and further increased up to amplitude 3, if individually possible, always using frequencies between 20-25Hz. Children also perform exercises on the platform, including shifting their weight from one side to the other, increase/decrease their knee and hip angle, weight shift with trunk rotation, and alternate flexion and extension of knees.

    Device: Galileo M

  • No intervention
    Regular Care

    Regular Care, including physiotherapy for 5 months

Interventions

  • DeviceGalileo M

    Motorized board producing side-to-side alternating vertical sinusoidal (rotational) vibrations around a fulcrum in the mid-section of the plate. The vibration frequency can be selected by the user who stands on the board with both feet, wearing shoes. The peak-to-peak displacement to which the feet are exposed increases with the distance of the feet from the centre line of the vibrating board. Three positions marked 1, 2 and 3 are indicated on the vibrating board, corresponding to peak-to-peak displacements of 2, 4, and 6mm. The peak acceleration exerted by vibration exercise increases with higher frequencies and higher amplitudes.

    Also known as: Vibraflex

06

What researchers measure

Primary outcomes

  1. Does WBVT increase bone density at the distal tibia

    Trabecular volumetric BMD measured at the distal tibia (4% of tibia length)

    Time frame: 5 months

Secondary outcomes

  1. Does WBVT result in an increase in dynamic muscle function

    Jumping Mechanography (single 2-leg jump, multiple one leg hop, chair and heel rise test)

    Time frame: 5 months

  2. Does WBVT result in an increase in muscle mass

    Muscle mass measured by DXA

    Time frame: 5 months

  3. Does WBVT result in an increase in density

    Bone density measured by DXA

    Time frame: 5 months

  4. Does WBVT result in an increase in density of the tibia

    Bone density measured by pQCT

    Time frame: 5 months

  5. Does WBVT result in an increase in bone geometry

    Bone size measured by pQCT

    Time frame: 5 months

  6. Does WBVT result in an increase in 6-minute walking distance

    six minute walk tests

    Time frame: 5 months

  7. Does WBVT result in improved disability

    CHAQ disability score

    Time frame: 5 months

  8. Does WBVT result in improved balance

    Balance (sway area measured by mechanography)

    Time frame: 5 months

07

Study locations

1 site
  • Birmingham Children's Hospital
    Birmingham, B46NH, United Kingdom
08

References and documents

Publications

  • Hogler W, Scott J, Bishop N, Arundel P, Nightingale P, Mughal MZ, Padidela R, Shaw N, Crabtree N. The Effect of Whole Body Vibration Training on Bone and Muscle Function in Children With Osteogenesis Imperfecta. J Clin Endocrinol Metab. 2017 Aug 1;102(8):2734-2743. doi: 10.1210/jc.2017-00275. PubMed 28472303 ↗

Individual participant data

Plan to share: Yes — Anonymised data available on request, subject to Ethical and R\&D guidelines

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 24, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03029312
Lead sponsor
Birmingham Women's and Children's NHS Foundation Trust
Collaborators
Royal Manchester Children' s Hospital, Manchester, University of Sheffield
Responsible party
Sponsor
First posted
Jan 24, 2017
Start date
Jan 17, 2012
Primary completion
Nov 18, 2015
Completion
Jan 18, 2016
Last update
Jan 24, 2017

Study contacts

Wolfgang Högler, MD PD
principal investigator · Birmingham Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion